Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3036005	u-sakkaa	— (—)	45	49	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Oxycodone

8.80

7.77

1.0

1.2

—

Constipation

4.88

6.23

1.2

1.0

—

Other bacterial diseases

4.71

5.93

1.0

1.2

—

Asthma (only as main-diagnosis)

6.03

5.64

1.0

1.3

—

Asthma (only as main-diagnosis), excluding more controls

5.96

5.55

1.0

1.3

—

First line medication for Crohn's disease

4.21

5.43

1.1

—

Other diseases of spinal cord

+∞

5.21

1.4

0.0

—

Codeine

4.81

5.15

1.0

1.3

—

Intestinal infectious diseases

3.89

4.96

1.0

1.1

—

Tramadol

5.44

4.86

1.0

1.3

—

ILD medications

3.73

4.74

1.2

1.0

—

Early onset COPD, excluding more controls

14.00

4.57

1.1

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

3.77

4.57

1.1

1.0

—

Oral corticosteroids

3.59

4.40

1.1

—

3.67

4.32

1.0

1.2

—

Asthma (mode)

5.03

4.23

1.0

1.3

—

Chronic lower respiratory diseases

3.41

4.20

1.1

—

Asthma

4.92

4.10

1.0

1.3

—

Certain infectious and parasitic diseases

4.62

4.09

1.3

1.1

—

COPD/asthma related infections

3.76

4.08

1.1

1.2

—

COPD/asthma/ILD related infections

3.76

4.08

1.1

1.2

—

Asthma, excluding more controls

4.89

4.06

1.0

1.3

—

Malignant neoplasm

4.19

3.96

1.1

—

Abnormalities of breathing

3.62

3.88

1.0

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

4.17

3.83

1.0

1.2

—

Dyspnoea

3.56

3.83

1.0

1.1

—

Inflammatory bowel disease treatment related agents

3.25

3.78

1.1

—

Early onset COPD

8.76

3.77

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs

11.05

3.58

1.0

1.2

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

7.78

3.55

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

3.49

3.55

1.0

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.95

3.54

1.0

1.2

—

Any reimbursement code in KELA

8.02

3.47

1.4

1.0

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

3.73

3.47

1.1

1.2

—

Malignant neoplasm, wide definition for exclusion

3.73

3.47

1.1

1.2

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

3.73

3.46

1.1

1.2

—

Other symptoms and signs involving the nervous and musculoskeletal systems

5.71

3.33

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

3.26

3.27

1.0

1.1

—

COPD (mode)

9.52

3.26

1.2

—

Bronchitis

3.06

3.20

1.0

1.1

—

Other reaction to severe stress, and adjustment disorders

5.34

3.19

1.0

1.2

—

Renal tubulo-interstitial diseases

3.29

3.18

1.1

—

Other chronic obstructive pulmonary disease

5.54

3.17

1.1

—

COPD

5.50

3.15

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

8.39

3.12

1.0

—

Disorders of the thyroid gland

3.15

3.09

1.1

—

Cholecystectomy

3.54

3.05

1.0

1.2

—

Chronic rhinitis, nasopharyngitis and pharyngitis

7.50

3.05

1.2

1.4

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

6.15

3.05

1.0

1.1

—

Exclusions for E4_PCOS_BROAD

10.00

2.97

1.0

1.2

—

Heart failure, not strict

3.63

2.94

1.0

1.1

—

Persons encountering health services in other circumstances

5.38

2.86

1.0

1.1

—

5.34

2.85

1.0

1.3

—

Anxiety disorders, excluding more controls

3.31

2.84

1.0

1.1

—

Disorders of other endocrine glands

5.30

2.83

1.0

1.3

—

Autoimmune diseases related-to ILD

3.12

2.81

1.3

1.0

—

Asthma, unspecified (mode)

5.55

2.81

1.0

1.3

—

Asthma, unspecified (mode), excluding more controls

5.50

2.79

1.0

1.3

—

Codeine or tramadol medication

2.87

2.77

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

8.34

2.75

1.4

1.2

—

GASTRO-related operations

4.52

2.75

1.1

1.2

—

Any gastric operation

4.52

2.75

1.1

1.2

—

Any event in cancer register

3.26

2.68

1.1

1.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

3.75

2.66

1.0

1.2

—

Hallux valgus (acquired)

5.07

2.60

1.0

1.2

—

Other headache syndromes

4.67

2.59

1.0

1.3

—

Diseases of oesophagus, stomach and duodenum

2.82

2.58

1.0

1.1

—

Sleep disorders (combined)

2.91

2.56

1.0

1.1

—

Other strabismus

7.12

2.54

1.0

1.1

—

Pain, not elsewhere classified

5.46

2.54

1.0

1.4

—

Chronic kidney disease

5.43

2.53

1.0

1.2

—

Exclusions for E4_PCOS_CONSORTIUM

3.30

2.53

1.0

1.2

—

Benzodiazepine use

2.85

2.52

1.0

1.1

—

COPD, hospital admissions

3.98

2.49

1.1

—

COPD, early/later onset

3.97

2.49

1.1

—

Other diseases of intestines

2.91

2.47

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

3.91

2.45

1.1

—

Other acute lower respiratory infections

3.82

2.45

1.0

1.2

—

Acute upper respiratory infections

2.71

2.44

1.0

1.1

—

Acute sinusitis

3.73

2.39

1.0

1.2

—

Other abnormal uterine and vaginal bleeding

7.13

2.38

1.0

—

Irritable bowel syndrome

6.25

2.37

1.0

1.3

—

Strabismus

6.24

2.37

1.0

1.1

—

Renal failure

4.00

2.27

1.0

1.1

—

Noninfective enteritis and colitis

3.88

2.24

1.0

1.2

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

3.86

2.23

1.0

1.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

5.56

2.21

1.4

1.1

—

Cholelithiasis

2.92

2.19

1.0

1.2

—

Other neurological diseases

3.15

2.19

1.2

1.1

—

Opioids

3.09

2.18

1.0

1.2

—

Mouth breathing

4.28

2.15

1.0

1.1

—

Asthma, hospital admission 2, infections

3.28

2.14

1.0

1.2

—

Asthma-related infections

3.28

2.14

1.0

1.2

—

Acute bronchitis

4.20

2.11

1.0

1.3

—

Cholelithiasis, broad definition with cholecystitis

2.86

2.11

1.0

1.2

—

Acute tubulo-interstitial nephritis

3.23

2.07

1.1

—

Obesity related asthma

5.00

2.07

1.0

1.2

—

Sleep apnoea

2.83

2.07

1.0

1.1

—

Dentinal caries

4.98

2.06

1.0

1.4

—

Dental caries

4.95

2.05

1.0

1.4

—

Persons encountering health services in other circumstances, wide

2.50

2.02

1.2

1.0

—

Neurotic, stress-related and somatoform disorders

2.61

2.01

1.0

1.1

—

Asthma, including avohilmo

2.44

1.99

1.0

1.1

—

Menorrhagia

5.53

1.97

1.0

—

Other and unspecified tonsillitis

3.92

1.96

1.0

1.2

—

COPD related to multimorbidity

3.89

1.94

1.0

—

Exposure to unspecified factor

2.51

1.92

1.0

1.1

—

Anxiety disorders

2.51

1.89

1.0

1.1

—

Inguinal hernia

3.37

1.87

1.1

—

Hypothyroidism, other/unspecified

2.64

1.84

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3.80

1.82

1.0

1.2

—

Gastro-oesophageal reflux disease

2.83

1.82

1.0

1.2

—

COPD, hospital admission 2, with asthma infections

4.27

1.81

1.0

—

3.06

1.79

1.0

1.2

—

Viral infections characterized by skin and mucous membrane lesions

3.33

1.74

1.0

1.2

—

Osteopathies and chondropathies

3.35

1.74

1.2

1.1

—

Polycystic ovarian syndrome, consortium definition

2.84

1.72

1.3

1.1

—

Other soft tissue disorders, not elsewhere classified

2.43

1.72

1.0

1.1

—

Asthma (diagnoses ohter than nonallergic)

2.44

1.70

1.0

1.1

—

Mental and behavioural disorders due to psychoactive substance use

2.87

1.68

1.0

1.2

—

Low back pain

2.68

1.68

1.0

1.1

—

2.85

1.66

1.0

1.2

—

Falls/tendency to fall

2.24

1.65

1.2

1.1

—

Symptoms and signs involving the urinary system

2.58

1.60

1.0

1.1

—

Other antidepressants

2.39

1.60

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.64

1.60

1.1

1.2

—

2.64

1.60

1.1

1.2

—

Substance abuse, excluding more controls

3.09

1.60

1.0

1.1

—

Psychiatric diseases

2.39

1.59

1.2

1.1

—

Any mental disorder

2.39

1.59

1.2

1.1

—

Episodal and paroxysmal disorders

2.28

1.58

1.0

1.1

—

Venous thromboembolism

2.91

1.53

1.0

1.1

—

Influenza and pneumonia

2.26

1.53

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2.36

1.51

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.58

1.50

1.1

—

Erysipelas

2.88

1.50

1.0

1.1

—

Dorsalgia

2.29

1.50

1.0

1.1

—

Bacterial infection, other or unspecified

2.85

1.48

1.0

1.1

—

Unspecified haematuria

3.30

1.48

1.0

1.2

—

Complications of procedures, not elsewhere classified

2.43

1.47

1.1

—

Sleep apnoea, including avohilmo

2.32

1.46

1.0

1.1

—

Mood disorders, excluding more controls

2.38

1.43

1.0

1.1

—

Asthma/COPD (KELA code 203)

2.35

1.43

1.0

1.1

—

Gastrointestinal diseases

3.01

1.43

1.2

—

Other diseases of urinary system

2.21

1.41

1.3

1.0

—

Implicit bacterial Sepsis

3.06

1.39

1.0

1.1

—

Hernia

2.26

1.38

1.1

—

Substance abuse

2.61

1.36

1.0

1.2

—

Malaise and fatigue

2.63

1.35

1.0

1.2

—

Other septicaemia

2.89

1.33

1.0

1.1

—

Pneumonia, organism unspecified

2.17

1.32

1.1

—

Spondylopathies

2.43

1.30

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

2.40

1.30

1.0

1.2

—

ILD medications: immunosuppressive drugs

2.50

1.30

1.5

1.0

—

All pneumoniae

2.16

1.28

1.1

—

Other diseases of upper respiratory tract

2.12

1.28

1.1

—

Bacterial Sepsis

2.78

1.27

1.0

1.1

—

Pain in limb

2.31

1.27

1.0

1.2

—

Diseases of arteries, arterioles and capillaries

2.49

1.25

1.0

1.1

—

Concussion

2.70

1.23

1.0

1.1

—

Septicaemia

2.67

1.23

1.0

1.1

—

Injuries to the thorax

2.63

1.21

1.0

1.1

—

Depression

2.09

1.20

1.0

1.1

—

Varicose veins

2.39

1.19

1.0

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

2.11

1.19

1.0

1.1

—

Major coronary heart disease event

0.00

1.19

0.0

1.1

—

Visual disturbances and blindness

2.31

1.18

1.0

1.2

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.31

1.18

1.2

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.11

1.18

1.3

1.0

—

Endocrine, nutritional and metabolic diseases

2.14

1.15

1.1

1.2

—

Persons encountering health services for specific procedures and health care

2.06

1.14

1.0

1.1

—

Spondylosis

2.52

1.14

1.2

1.1

—

Lower back pain or/and sciatica

2.04

1.14

1.0

1.1

—

Irregular menses

2.53

1.14

1.4

1.1

—

Diabetes, varying definitions

2.06

1.13

1.0

1.1

—

Diabetes mellitus

2.06

1.13

1.0

1.1

—

Other diseases of pleura

2.46

1.11

1.0

1.1

—

Other heart diseases

2.54

1.11

1.0

1.3

—

Mental and behavioural disorders due to alcohol

2.43

1.11

1.0

1.2

—

Neurological diseases

2.16

1.10

1.3

1.0

—

Unspecified fall

2.36

1.08

1.0

1.2

—

Mood [affective] disorders

1.99

1.07

1.0

1.1

—

Mood disorders

1.99

1.07

1.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.03

1.06

1.2

1.1

—

Complications of surgical and medical care, not elsewhere classified

2.02

1.05

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.02

1.05

1.0

1.1

—

Diseases of the respiratory system

2.51

1.05

1.2

—

Alcohol use disorder, Swedish definition

2.32

1.05

1.0

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.98

1.04

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.96

1.03

1.0

1.1

—

Intracranial trauma

2.33

1.03

1.0

1.1

—

Complications of medical and surgical care

2.08

1.03

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

1.95

1.03

1.1

—

Sciatica+with lumbago

2.26

1.02

1.0

1.1

—

Sensorineural hearing loss

2.04

1.00

1.0

1.1

—

Other pulmonary diagnosis

2.50

0.99

1.0

1.3

—

Excluding asthma or asthma-COPD overlap

2.50

0.99

1.0

1.3

—

COPD differential diagnosis

2.50

0.99

1.0

1.2

—

ILD differential diagnosis

2.50

0.99

1.0

1.2

—

Exposure to other specified factors

1.99

0.99

1.1

—

Dorsopathies

1.96

0.98

1.1

—

Allergic conjunctivitis

0.00

0.97

0.0

1.1

—

Finngen Rheumatological endpoints

1.83

0.96

1.0

1.1

—

Injuries to the wrist and hand

1.81

0.96

1.0

1.1

—

Conductive and sensorineural hearing loss

1.94

0.94

1.0

1.1

—

Parasetamol

2.19

0.91

1.2

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.93

0.89

1.0

1.1

—

Type 2 diabetes, definitions combined

1.91

0.89

1.0

1.2

—

Implicit Sepsis

2.03

0.87

1.0

1.2

—

Type 2 diabetes, strict (exclude DM1)

1.84

0.86

1.0

1.2

—

Type 2 diabetes, definitions combined, including avohilmo

1.82

0.85

1.0

1.2

—

Cystitis

1.81

0.85

1.3

1.0

—

Appendectomy

1.93

0.84

1.0

1.1

—

Type 2 diabetes

1.76

0.82

1.0

1.1

—

Gonarthrosis

1.91

0.81

1.0

1.1

—

Dizziness and giddiness

1.87

0.81

1.3

1.1

—

Headache

1.86

0.80

1.0

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

0.00

0.80

0.0

1.1

—

Fracture of forearm

0.00

0.79

0.0

1.2

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.00

0.79

0.0

1.0

—

Other joint disorders

1.78

0.78

1.0

1.1

—

Transport accidents

0.00

0.78

0.0

1.1

—

Genitourinary diseases

2.28

0.78

1.2

1.0

—

Diabetes medication

1.76

0.78

1.0

1.1

—

Depression or dysthymia

2.15

0.75

1.0

—

Dermatitis and eczema

1.69

0.75

1.0

1.1

—

General symptoms and signs

1.67

0.75

1.0

1.1

—

Visual disturbances

2.08

0.74

1.0

1.2

—

Diseases of inner ear

2.04

0.73

1.4

1.1

—

Insulin medication

1.86

0.68

1.0

1.2

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.84

0.68

1.0

1.2

—

Disorders of eyelid, lacrimal system and orbit

1.66

0.68

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

1.83

0.67

1.0

1.1

—

Disorders of sclera, cornea, iris and ciliary body

1.79

0.66

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

1.74

0.65

1.0

1.2

—

Use of hypnotics and sedatives

1.71

0.64

1.0

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.70

0.64

1.0

1.1

—

Used for control exclusion in common control thyroid runs

1.62

0.62

1.4

1.0

—

Coronary revascularization (ANGIO or CABG)

0.00

0.61

0.0

1.1

—

Injuries to the hip and thigh

0.00

0.60

0.0

1.1

—

Shoulder lesions

1.84

0.60

1.0

1.1

—

Pain in throat and chest

1.83

0.60

1.0

1.2

—

Obesity due to excess calories

0.00

0.60

0.0

1.2

—

Hypertension, essential

1.80

0.60

1.0

1.1

—

Emergency coronary revascularization (for ACS)

0.00

0.59

0.0

1.1

—

Other intervertebral disc disorders

1.75

0.59

1.2

1.1

—

Disorders of breast

0.00

0.58

0.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.68

0.57

1.0

1.2

—

Symptoms and signs involving the skin and subcutaneous tissue

1.66

0.56

1.2

1.1

—

Autoimmune diseases

1.53

0.56

1.3

1.0

—

Parodontitis and operation codes

1.61

0.55

1.0

1.1

—

Gonarthrosis [arthrosis of knee](FG)

1.61

0.55

1.0

1.1

—

Gonarthrosis,primary

1.57

0.54

1.0

1.1

—

Fall on same level

1.44

0.53

1.2

1.1

—

Chronic periodontitis, including avohilmo

1.53

0.52

1.0

1.1

—

Parodontitis

1.52

0.52

1.0

1.1

—

Parodontitis or operation codes

1.52

0.52

1.0

1.1

—

Other disorders of ear

1.61

0.50

1.0

1.1

—

Gingivitis and periodontal diseases

1.57

0.50

1.0

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

1.70

0.44

1.0

1.2

—

Injury, poisoning and certain other consequences of external causes

1.67

0.44

1.2

1.1

—

Other diseases of hard tissues of teeth

1.62

0.43

1.0

1.2

—

Contraceptive management

0.00

0.42

0.0

1.0

—

Peripheral artery disease

0.00

0.41

0.0

1.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.41

0.0

1.1

—

Arthrosis

1.53

0.41

1.0

1.1

—

Coronary angioplasty

0.00

0.41

0.0

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

0.00

0.41

0.0

1.1

—

Rheumatoid arthritis, including avohilmo

0.00

0.41

0.0

1.1

—

Rheumatoid arthritis

0.00

0.41

0.0

1.1

—

Hypothyroidism, strict autoimmune

1.50

0.41

1.2

1.0

—

Myocardial infarction, without ST-elevation

0.00

0.40

0.0

1.1

—

Presence of cardiac and vascular implants and grafts

0.00

0.40

0.0

1.1

—

Unstable angina pectoris

0.00

0.40

0.0

1.1

—

Valvular heart disease excluding rheumatic fever

0.00

0.40

0.0

1.1

—

Non-rheumatic valve diseases

0.00

0.40

0.0

1.1

—

Other symptoms and signs involving cognitive functions and awareness

0.00

0.40

0.0

1.1

—

Other anxiety disorders

0.00

0.39

0.0

1.2

—

Hypertensive diseases

1.41

0.39

1.0

1.1

—

Hypertension

1.41

0.39

1.0

1.1

—

Injuries to the shoulder and upper arm

1.40

0.38

1.2

1.1

—

Other (not insulin) diabetes medications

1.34

0.34

1.0

1.1

—

Other heart diseases, wide

1.33

0.34

1.0

1.1

—

Biguanides

1.32

0.33

1.0

1.1

—

Abdominal and pelvic pain

1.35

0.32

1.0

1.2

—

Symptoms and signs involving the digestive system and abdomen

1.35

0.32

1.0

1.2

—

Autoimmune diseases excluding thyroid diseases

1.34

0.31

1.3

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.41

0.24

1.6

1.1

—

Neoplasms

1.41

0.24

1.0

1.2

—

Artificial joint operation, meniscal resection

1.28

0.23

1.0

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.26

0.23

1.2

1.1

—

Other specific joint derangements/joint disorders

1.24

0.22

1.0

1.1

—

Single delivery by caesarean section

0.00

0.22

0.0

1.0

—

Dental pulpitis 3

0.00

0.22

0.0

1.3

—

Special screening examination for infectious and parasitic diseases

0.00

0.22

0.0

1.0

—

Hypertensive heart and/or renal disease

0.00

0.21

0.0

1.1

—

Diabetic retinopathy, strict definition

0.00

0.21

0.0

1.0

—

Postpartum haemorrhage

0.00

0.21

0.0

1.0

—

Erosion of teeth, including avohilmo

0.00

0.21

0.0

1.1

—

Other hearing loss

0.00

0.21

0.0

1.2

—

All dysplastic lesions of the cervix uteri

0.00

0.21

0.0

1.3

—

Chronic gastritis

0.00

0.21

0.0

1.2

—

Fibroblastic disorders

0.00

0.21

0.0

1.2

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.21

0.0

1.1

—

Primary coxarthrosis, bilateral

0.00

0.21

0.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.21

0.0

1.1

—

Seropositive rheumatoid arthritis, wide

0.00

0.21

0.0

1.1

—

Soft tissue disorders related to use, overuse and pressure

0.00

0.21

0.0

1.2

—

Psoriasis

0.00

0.21

0.0

1.2

—

Postpartum hemorraghe, all women as controls

0.00

0.21

0.0

1.3

—

Calcific aortic valvular stenosis, operated

0.00

0.21

0.0

1.1

—

Calcific aortic valvular stenosis

0.00

0.21

0.0

1.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

0.21

0.0

1.1

—

Operations 2 for CAVS

0.00

0.21

0.0

1.1

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.21

0.0

1.1

—

Selective serotonin reuptake inhibitors

1.32

0.21

1.2

1.1

—

Diseases of external ear

0.00

0.21

0.0

1.2

—

Preterm labour and delivery

0.00

0.21

0.0

1.0

—

Deviated nasal septum

0.00

0.21

0.0

1.1

—

Coronary artery bypass grafting

0.00

0.21

0.0

1.1

—

Sub-endpoint used in defining T1D endpoints

0.00

0.21

0.0

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.29

0.21

1.3

1.0

—

False labour

0.00

0.21

0.0

1.0

—

Metabolic disorders

1.28

0.21

1.0

1.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.00

0.20

0.0

1.2

—

Postpartum hemorraghe, parous women as controls

0.00

0.20

0.0

1.3

—

Other dorsopathies, not elsewhere classified

1.22

0.20

1.0

1.1

—

Heart failure and coronary heart disease

0.00

0.20

0.0

1.1

—

Injuries to the head

1.20

0.18

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

1.17

0.18

1.0

1.1

—

Diseases of the ear and mastoid process

1.19

0.17

1.3

1.1

—

Diseases of the eye and adnexa

1.19

0.10

1.6

1.0

—

Soft tissue disorders

1.11

0.09

1.0

1.1

—

Dental pulpitis 1, only avohilmo

0.77

0.08

1.0

1.1

—

Dental pulpitis 4, only avohilmo

0.77

0.08

1.0

1.1

—

Dental pulpitis 1

0.76

0.08

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

0.76

0.08

1.0

1.1

—

Dental pulpitis 4

0.76

0.08

1.0

1.1

—

Injuries to the knee and lower leg

1.05

0.08

1.1

—

Benign neoplasm of ovary

0.00

0.0

1.2

—

Missing teeth due to accident, extraction or parodontitis

0.00

0.0

1.4

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.0

1.0

—

Ganglion

0.00

0.0

1.2

—

Impacted teeth

0.00

0.0

1.3

—

Ectopic pregnancy

0.00

0.0

1.1

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

0.0

1.0

—

Diabetic neuropathy

0.00

0.0

1.0

—

Continuous positive airway pressure

0.00

0.0

1.4

—

Sarcoidosis

0.00

0.0

1.2

—

Polyuria

0.00

0.0

1.3

—

Benign mammary dysplasia

0.00

0.0

1.2

—

Certain disorders involving the immune mechanism

0.00

0.0

1.2

—

Hydrocele

0.00

0.0

1.2

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.0

1.0

—

Prolonged pregnancy

0.00

0.0

1.0

—

Cervicobrachial syndrome

0.00

0.0

1.2

—

Disturbance of activity and attention

0.00

0.0

1.2

—

Haemorrhage from respiratory passages

0.00

0.0

1.2

—

Aortic aneurysm

0.00

0.0

1.1

—

Other hammer toe(s) (acquired)

0.00

0.0

1.1

—

Other female pelvic inflammatory diseases

0.00

0.0

1.2

—

Tinnitus

0.00

0.0

1.3

—

Superficial injury of ankle and foot

0.00

0.0

1.2

—

Nerve, nerve root and plexus disorders

0.95

0.00

1.0

1.1

—

Coeliac disease

0.00

0.0

1.2

—

Spondylolisthesis/Spondylolysis

0.00

0.0

1.2

—

Type 1 diabetes, wide definition

0.00

0.0

1.3

—

Type 1 diabetes, wide definition, subgroup 1

0.00

0.0

1.3

—

Childhood allergy (age < 16)

0.00

0.0

1.3

—

Benign neoplasm of breast

0.00

0.0

1.2

—

Traumatic subdural haemorrhage

0.00

0.0

1.2

—

Car occupant injured in other and unspecified transport accidents

0.00

0.0

1.2

—

Unspecified lump in breast

0.00

0.0

1.2

—

Pedal cyclist injured in transport accident

0.00

0.0

1.1

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Methotrexate

0.00

0.0

1.2

—

Recurring oral aphthae, including avohilmo

0.00

0.0

1.2

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.0

1.2

—

Seropositive rheumatoid arthritis

0.00

0.0

1.2

—

Speech therapy

0.00

0.0

1.2

—

Hypertrophy of breast

0.00

0.0

1.2

—

Long labour

0.00

0.0

1.0

—

Supervision of high-risk pregnancy

0.00

0.0

1.0

—

Otitis media, unspecified

0.00

0.0

1.1

—

Benign neoplasm of ovary

0.00

0.0

1.2

—

Otitis externa

0.00

0.0

1.2

—

Psoriasis vulgaris

0.00

0.0

1.3

—

Type 1 diabetes

0.00

0.0

1.3

—

Use of anticholinesterases

0.00

0.0

1.0

—

Use of donepezil

0.00

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

0.0

1.2

—

Dental pulpitis 3, only avohilmo

0.00

0.0

1.3

—

Diseases of salivary glands

0.00

0.0

1.5

—

Hyperkinetic disorders

0.00

0.0

1.2

—

Infections of genitourinary tract in pregnancy

0.00

0.0

1.6

—

Retinal breaks without detachment

0.00

0.0

1.2

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.0

1.4

—

Polyarthrosis

0.00

0.0

1.1

—

Endometriosis ASRM stages 3,4

0.00

0.0

1.1

—

Familial hypercholesterolemia

0.00

0.0

1.1

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.0

1.1

—

Acute appendicitis, with complications

0.00

0.0

1.2

—

Hallux rigidus

0.00

0.0

1.3

—

Myocardial infarction, unclassifiable

0.00

0.0

1.0

—

Multiple delivery

0.00

0.0

1.0

—

Biological medication for rheuma

0.00

0.0

1.2

—

Palmar fascial fibromatosis [Dupuytren]

0.00

0.0

1.2

—

L02BA Anti-estrogens

0.00

0.0

1.2

—

Puerperal sepsis

0.00

0.0

1.2

—

N06DA Anticholinesterases

0.00

0.0

1.0

—

Lyme disease

0.00

0.0

1.3

—

Hypertensive Heart Disease

0.00

0.0

1.1

—

Nontoxic multinodular goitre

0.00

0.0

1.0

—

Dementia in Alzheimer disease

0.00

0.0

1.0

—

HSIL lesion of the cervix uteri

0.00

0.0

1.6

—

Convulsions, not elsewhere classified

0.00

0.0

1.4

—

Fracture of femur

0.00

0.0

1.0

—

Fracture of foot, except ankle

0.00

0.0

1.1

—

Enthesopathies of lower limb, excluding foot

0.00

0.0

1.2

—

Other (seronegative) rheumatoid arthritis, wide

0.00

0.0

1.2

—

Obstructed labour due to maternal pelvic abnormality

0.00

-0.00

0.0

1.0

—

Injury of eye and orbit

0.00

-0.00

0.0

1.2

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Urine sediment comments by Light microscopy Narrative

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS